209984-68-9 Usage
Uses
Used in Pharmaceutical Development:
7-(S)-(N'-((S)-(+)-2-hydroxy-3-methylbutyryl)-L-alaninyl)amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one is used as a potential drug candidate for the treatment of neurological and psychiatric disorders due to its unique chemical structure and the possibility of it possessing pharmacological properties.
Used in Research and Development:
In the field of medicinal chemistry, 7-(S)-(N'-((S)-(+)-2-hydroxy-3-methylbutyryl)-L-alaninyl)amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one is used as a subject of research to explore its pharmacological properties and potential therapeutic effects, with the aim of advancing our understanding of its applications in treating specific medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 209984-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,9,8 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 209984-68:
(8*2)+(7*0)+(6*9)+(5*9)+(4*8)+(3*4)+(2*6)+(1*8)=179
179 % 10 = 9
So 209984-68-9 is a valid CAS Registry Number.
209984-68-9Relevant academic research and scientific papers
CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
-
Page/Page column 62; 82, (2009/02/10)
Disclosed are compounds which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
